Projects Funded
2022
Justin Balko, Pharm. D., Ph.D.
Vanderbilt-Ingram Cancer Center
Justin Balko, Pharm.D., Ph.D. and Carlos L. Arteaga, M.D. The goal of this grant is to utilize existing models of inflammatory breast cancer. In addition, Vanderbilt investigators were the first to identify and explore a particular variance – amplification of the JAK2 gene.
Carlos L. Arteaga, M.D.
Vanderbilt-Ingram Cancer Center
Justin Balko, Pharm.D., Ph.D. and Carlos L. Arteaga, M.D. The goal of this grant is to utilize existing models of inflammatory breast cancer. In addition, Vanderbilt investigators were the first to identify and explore a particular variance – amplification of the JAK2 gene.
Continuing Medical education
Baylor College of Medicine
Sponsorship for this CME aimed to enhance the knowlege of oncologists in the management of advanced breasta cancer and how to implement the emerging therapies and cuttin edge techniques into day to day practice.
MD Anderson boot walk to end cancer
The University of Texas MD Anderson Cancer Center
Matching grant for this annual fundraiser that provides support for patient programs, research, prevention and education at MD Anderson — and 100% of funds raised by participants directly support MD Anderson’s mission to end cancer.
7th international inflammatory breast cancer symposium
The University of Texas MD Anderson Cancer Center
This two-day meeting is targeted for clinical investigators, physicians, basic researchers, nurses, patient advocates and institutions aiming to pioneer IBC clinics in their geographic regions, to enhance their knowledge and to facilitate collaboration to accelerate clinical therapy and research trial development beneficial for patients with IBC. We expect new ideas and collaborations from this meeting to lead to improvement of disease outcome, such as survival or tumor response, over the next 3 years.
The James
The James Cancer Hospital’s Stefanie Spielman Comprehensive Breast Center
The James Cancer Hospital’s Stefanie Spielman Comprehensive Breast Center recently launched an inflammatory breast cancer (IBC) program. The IBC program is the first in the state of Ohio and one of only a handful in the nation. Proceeds from our fundraiser will be used for research on why inflammatory breast cancer has such a unique pattern or spread and aggressive course.
2021
Justin Balko, Pharm. D., Ph.D.
Vanderbilt-Ingram Cancer Center
Justin Balko, Pharm.D., Ph.D. and Carlos L. Arteaga, M.D. The goal of this grant is to utilize existing models of inflammatory breast cancer. In addition, Vanderbilt investigators were the first to identify and explore a particular variance – amplification of the JAK2 gene.
Carlos L. Arteaga, M.D.
Vanderbilt-Ingram Cancer Center
Justin Balko, Pharm.D., Ph.D. and Carlos L. Arteaga, M.D. The goal of this grant is to utilize existing models of inflammatory breast cancer. In addition, Vanderbilt investigators were the first to identify and explore a particular variance – amplification of the JAK2 gene.
Gayathri Devi, Ph.D.
Duke University School of Medicine
Dr. Gayathri Devi’s research in the area of developing models to characterize inflammatory breast cancer metastasis to the brain.
MD Anderson boot walk to end cancer
The University of Texas MD Anderson Cancer Center
Matching grant for this annual fundraiser that provides support for patient programs, research, prevention and education at MD Anderson — and 100% of funds raised by participants directly support MD Anderson’s mission to end cancer.
Jimmy Fund Walk
Dana Farber Cancer Institute
Matching grant for this annual fundraiser that benefits Dana-Farber Cancer Institute’s lifesaving mission to provide compassionate patient care and groundbreaking cancer research for children and adults.
